G1 Therapeutics, Inc. announced it raised $50 Million in an amended filing from an offering of $50 Million

Jul 01, 2016•about 9 years ago

Amount Raised

$50 Million

Research Triangle ParkBiotechnology

Company Information

Company

G1 Therapeutics, Inc.

Location

79 T.W. ALEXANDER DRIVE

Research Triangle Park, North Carolina, United States

About

G1 Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of innovative therapies that improve the lives of those affected by cancer.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

G1 Therapeutics, Inc. announced it raised $50 Million in an amended filing from an offering of $50 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information